University of Minnesota. Driven to Discover.
Fully 67.8% of patients received antibiotics for longer than recommended.
Viruses account for 61.4% of cases in young kids, with RSV the most common viral cause and the leading cause of severe pneumonia.
The new drug is a 'modernized' version of tetracycline, designed to address antibiotic resistance, but its clinical role isn't yet clear.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.